Taking semaglutide with metformin: what you need to know

You take metformin every morning. Now semaglutide is on your radar.

Perhaps your GP mentioned Wegovy. Perhaps you saw a headline about weight-loss injections and checked your repeat prescriptions, wondering whether metformin rules you out. It doesn't. Metformin is one of the most prescribed medicines in the UK, taken by millions of people with type 2 diabetes and, less commonly, for conditions such as polycystic ovary syndrome. Semaglutide has its own well-established safety record. The two medicines work by completely different routes: metformin primarily reduces the amount of glucose your liver releases into the blood and improves your cells' response to insulin, while semaglutide mimics a gut hormone called GLP-1 that slows gastric emptying, reduces appetite and prompts the pancreas to release insulin in a glucose-dependent way. Because the mechanisms don't overlap or clash, prescribers routinely manage patients on both. What your prescriber will want to know is not whether the combination is theoretically acceptable (it is) but whether it is right for you, given your kidney function, your HbA1c, any other medicines you take, and your overall health goals.

What the combination actually means for blood sugar, and when to be alert

Neither metformin nor semaglutide carries a high standalone risk of hypoglycaemia (low blood sugar), which is one reason their combination tends to be well tolerated compared with, say, adding a sulphonylurea. Metformin doesn't cause a sharp insulin spike; semaglutide's insulin-stimulating effect is glucose-dependent, meaning it largely switches off when glucose levels are already low. Even so, if you are on metformin for type 2 diabetes and you add semaglutide, your overall blood-glucose control may improve noticeably. That's usually the goal, but it does mean your prescriber may want to review your metformin dose over time, and it's worth tracking any unusual dizziness, sweating or shakiness in the early weeks. The NHS patient information for semaglutide outlines the side effects and interactions worth monitoring. If you take any other diabetes medicines alongside metformin (insulin in particular) tell your prescriber before starting semaglutide, as the risk calculus changes. Semaglutide also slows the rate at which your stomach empties, which can affect how quickly you absorb other oral medicines. This isn't usually clinically significant for metformin, but it's one reason your whole medication history matters to the prescribing assessment.

Why Wegovy's eligibility criteria still apply, whatever you're already on

Being on metformin doesn't grant automatic access to semaglutide for weight management, and it doesn't block it either. The licensed weight-management product is Wegovy, and eligibility for it is based on BMI and the presence of weight-related conditions. The Wegovy SmPC and NICE guidance (TA875) describe the criteria: broadly, a BMI of 30 or above, or a BMI of 27 or above alongside at least one qualifying condition such as type 2 diabetes, high blood pressure or dyslipidaemia. Lower thresholds apply for some ethnic backgrounds under UK guidance. If you already have type 2 diabetes managed with metformin, that condition itself may contribute to your eligibility picture, which is worth discussing with a prescriber rather than assuming either way. You can read more about how BMI interacts with Wegovy eligibility if you want the numbers before your consultation, and our dedicated page on how BMI thresholds work specifically for semaglutide breaks this down in further detail, including what applies if your reading sits closer to the lower end of the range, such as what a BMI of 25 means for semaglutide eligibility or whether a BMI of 26 is enough to qualify for semaglutide treatment. The prescriber also checks kidney function: metformin is contraindicated in significant renal impairment, and semaglutide has its own renal considerations, so anyone on both needs that baseline established. This is standard, not unusual.

Getting a semaglutide prescription when you're already on metformin

The process at a regulated UK online pharmacy begins with a clinical consultation, a structured questionnaire that asks specifically about your current medications, including metformin, your dose, your prescribing GP and any recent blood tests. At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the day it comes in. They are not skimming for red flags; they are building a clinical picture. If they need clarification about your metformin history or recent kidney-function results, they'll ask. Once approved, your Wegovy pen is dispensed from our GPhC-registered pharmacy and arrives via DPD the next working day in a plain, unmarked box, tracked to your phone, refrigerated in transit, looking entirely unremarkable on the doorstep. People taking metformin often have an existing relationship with a GP who already holds relevant blood results, and our prescribers may recommend you share your prescription decision with them, in line with GPhC guidance on GP notification for online prescribing. For questions about how other medicines interact with semaglutide, our page on taking naproxen alongside semaglutide covers a common example of how these assessments work. If you're ready to see whether Wegovy fits your situation, the consultation is free and takes a few minutes to complete. Check your eligibility with our clinical team.